KENS 5: How a group of SA coronavirus patients helped the FDA fast-track approval of remdesivir

Drs. Thomas Patterson, chief of the Division of Infectious Diseases, and Jason Bowling, Infectious Diseases, explained the implications of the FDA fast-tracking emergency authorization of the new anti-viral drug, remdesivir, as the new standard of care for hospitalized COVID-19 patients.

Read and watch the full story.

Share This Article!